Watch for Gallbladder Problems in Patients Using GLP-1 Agonists
October 2016
You'll hear more about a possible link between gallbladder disease and GLP-1 agonists...such as Victoza (liraglutide) or Byetta (exenatide).
The latest evidence suggests that about one in 357 patients on liraglutide or exenatide over about 3 years will be hospitalized for bile duct or gallbladder disease...compared to patients on other diabetes meds.
We know that patients with diabetes already have a higher risk of bile duct and gallbladder disease. But GLP-1 agonists may increase this risk...possibly by causing rapid weight loss in some patients.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote